Related Experiment Video
Updated: May 9, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Self-Expanding Stent and Delivery System for Aortic Valve Replacement
Dumitru Mazilu1, Ming Li, Ozgur Kocaturk
1e-mail: mazilud@nhlbi.nih.gov.
Journal of Medical Devices
|August 7, 2013
Summary
A new self-expanding nitinol stent and delivery system enable precise, minimally invasive aortic valve replacement using MRI guidance. This approach offers better valve fixation and positioning for improved long-term heart function.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Medical Imaging
Background:
- Traditional aortic valve replacement necessitates sternotomy and cardiopulmonary bypass (CPB).
- Transcatheter aortic valve replacement (TAVR) offers a less invasive alternative for high-risk patients.
- Current TAVR methods require precise valve deployment, which can be challenging.
Purpose of the Study:
- To develop and evaluate a novel self-expanding nitinol stent for minimally invasive aortic valve replacement.
- To assess a delivery device designed for transapical TAVR under real-time magnetic resonance imaging (MRI) guidance.
- To improve the accuracy and predictability of bioprosthetic aortic valve implantation.
Main Methods:
- Development of a nitinol self-expanding stent with an integrated MRI passive marker.
- Design of a delivery device featuring an MRI active marker for real-time MRI guidance.
- Ex vivo and in vivo (porcine model) testing to evaluate stent performance, valve integrity, and implantation accuracy.
- Measurement of radial forces and chronic outward forces.
Main Results:
- The self-expanding stent demonstrated adequate reinforcement of the bioprosthetic aortic valve.
- The MRI markers facilitated precise and predictable orientation and positioning of the implanted valve.
- The stent design allows for potential retraction if necessary.
- Ex vivo and in vivo results confirmed ease of implantation and proper seating of the valve prosthesis.
- Histopathology confirmed the stent's biocompatibility and functionality.
Conclusions:
- The novel self-expanding nitinol stent system provides a precise and reliable method for transapical TAVR.
- Real-time MRI guidance with integrated markers enhances implantation accuracy and predictability.
- This technology holds promise for improved long-term heart function due to better prosthesis fixation.
